Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOsteoarthritis Treatment and Mechanisms · Bone Metabolism and Diseases · Genomics, phytochemicals, and oxidative stress
S. Li, Y. Shi, S. Zhang, et al., “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway,” Oxidative Medicine and Cellular Longevity 2022 (2022): 2188145, https://doi.org/10.1155/2022/2188145.
In the article titled, “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway,” there was an error in Figure 2. In Figure 2A, the MMP‐3 band is duplicated with ADAMTS‐5. This duplication originated from an error introduced by the publisher during the secondary image editing process. These are two distinct bands. The correct figure is shown below:
We apologize for this error.